3D Diagnostics moves to boost sales as shares slump

SHARES in Dundee-based 3D Diagnostic Imaging plunged more than 40 per cent yesterday after the dental equipment maker warned that “turbulent economic conditions” had taken a bite out of its revenues.

David Snow, one of the non-executive directors of Evolve Capital, the company’s largest shareholder, has now joined 3D’s board.

Snow guided brokerage Garban Europe to a stock market floatation before it was taken over by rival Icap.

3D, which makes devices that scan teeth for cavities, said the first half of its financial year had been tough, but it is bringing in measures that should boost sales during the first quarter of 2012.

Shares closed down 0.5p at 0.62p, wiping about £1 million off the firm’s market value.